CAMBRIDGE, Mass. and REDWOOD CITY, Calif. Biogen Idec and PDL BioPharma have licensed the antibody volociximab to treat age-related macular degeneration to Ophthotech, according to published reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback